Chinese health biotech and the billion-patient market
- 1 January 2008
- journal article
- review article
- Published by Springer Nature in Nature Biotechnology
- Vol. 26 (1) , 37-53
- https://doi.org/10.1038/nbt0108-37
Abstract
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.Keywords
This publication has 12 references indexed in Scilit:
- China syndrome—a regulatory framework in meltdown?Nature Biotechnology, 2007
- Hepatitis B in ChinaThe Lancet, 2007
- India's health biotech sector at a crossroadsNature Biotechnology, 2007
- Chinese biotech hamstrung by production issuesNature Biotechnology, 2007
- The development of China's medical biotech industry needs to be driven by innovationBiotechnology Journal, 2006
- Biopharmaceuticals in ChinaBiotechnology Journal, 2006
- Competing for talent: China's strategies to reverse the brain drainInternational Labour Review, 2006
- Can China bring its own pipeline to the market?Nature Biotechnology, 2004
- China approves first gene therapyNature Biotechnology, 2004
- The one that got awayNature Biotechnology, 2004